Correction to: The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. [PDF]
europepmc +1 more source
Becker muscular dystrophy mice showed site-specific decay of type IIa fibers with capillary change in skeletal muscle. [PDF]
Miyazaki D +4 more
europepmc +1 more source
Growth Hormone Secretagogue Receptor (GHSR) Is Elevated in Myocardial Tissues of DMD <i>mdx:utrn</i><sup>-/-</sup> Mice, and Correlates Strongly with Inflammatory Markers, and Negatively with Cardiac Function. [PDF]
Naghibosadat M +9 more
europepmc +1 more source
Dystrophin-Deficient Muscular Dystrophy in a Family of Shiba Inu Dogs with a Complex Deletion Encompassing <i>DMD</i> Exon 5. [PDF]
Mcleay L +6 more
europepmc +1 more source
Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy. [PDF]
Krishna L +6 more
europepmc +1 more source
Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy. [PDF]
Hart CC +6 more
europepmc +1 more source
Prostaglandins limit nuclear actin rod formation during <i>Drosophila</i> oogenesis. [PDF]
Tootle TL.
europepmc +1 more source
Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies. [PDF]
Haque US, Yokota T, Yokota T.
europepmc +1 more source

